Dr Jan Hoflack joins Oncodesign
This article was originally published in Scrip
Executive Summary
Dr Jan Hoflack has joined Oncodesign Biotechnology (France), a company focused on the identification of cancer therapies, as vice-president of drug discovery. Dr Hoflack was previously vice-president medicinal chemistry and biosciences at Johnson & Johnson Pharmaceutical R&D in Belgium.